Metagenomi

Digital gene editing technologies for drug development

placeBerkeley, California, United States calendar_todayFounded 2016 groups11 employees language metagenomi.co

Registered entities

Social engagement

Social engagement: 16.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

24 investors on record; lead investors include RA Capital Management, Bayer, Humboldt Fund, Novo Holdings.

Investor typeCountShare
Venture capital1250%
Private equity28%
Bank & private debt14%
Other / undisclosed938%

Recent activity

28 May 2026
Event
Jefferies Global Healthcare Conference
11 May 2026
Event
Advancing the Next Generation of Tools for Precision Editing In Vivo
12 Mar 2026
Event
Keystone Symposia Conference on Precision Genome Engineering: From Basic Mechanisms to Application
Coming soon